vidarabine has been researched along with Hemophilia A in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cambot, M; Cosset, FL; Costa, C; Dubart-Kupperschmitt, A; Joubert, C; Le Grand, R; Leboulch, P; Legrand, F; Nègre, D; Prost, S; Relouzat, F; Verhoeyen, E | 1 |
| Bilgrami, S; Mahipal, A | 1 |
| Chiang, KY; Doering, CB; Gangadharan, B; Ide, LM; Spencer, HT | 1 |
| Bendandi, M; Cantagalli, F; Macchi, S; Mancino, A; Simoncelli, F; Stefanati, V; Tura, S; Visani, G; Zaccaria, A; Zinzani, PL | 1 |
| Galloway, MJ; Hamilton, PJ; Tiplady, CW | 1 |
5 other study(ies) available for vidarabine and Hemophilia A
| Article | Year |
|---|---|
Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques.
Topics: Animals; Antigens, CD34; Chimerism; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; HEK293 Cells; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hemophilia A; Humans; Lymphocyte Count; Macaca fascicularis; Male; Myeloablative Agonists; Radiation-Sensitizing Agents; Recombinant Proteins; Simian Immunodeficiency Virus; Stem Cell Factor; Transduction, Genetic; Transplantation Conditioning; Transplantation, Autologous; Vidarabine; Whole-Body Irradiation | 2012 |
Acquired hemophilia in chronic lymphocytic leukemia.
Topics: Aged; Autoantibodies; Cyclophosphamide; Factor VIII; Female; Hemophilia A; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Time Factors; Treatment Outcome; Vidarabine | 2007 |
Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.
Topics: Animals; Antineoplastic Agents; Busulfan; Cyclophosphamide; Factor VIII; Genetic Therapy; Hematopoietic Stem Cell Transplantation; Hemophilia A; Humans; Mice; Swine; Transgenes; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2007 |
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Transfusion; Combined Modality Therapy; Cytarabine; Factor VIII; Female; Granulocyte Colony-Stimulating Factor; Hemophilia A; Hemorrhage; Hodgkin Disease; Humans; Immunologic Factors; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphatic Irradiation; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Plasmapheresis; Prednisone; Procarbazine; Prothrombin; Remission Induction; Thrombocytopenia; Vidarabine; Vincristine | 1995 |
Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine.
Topics: Antineoplastic Agents; Autoantibodies; Autoimmunity; Contusions; Hemophilia A; Hemorrhage; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Middle Aged; Vidarabine | 2000 |